CR10793A - Composiciones de carbamato fenilalquilo - Google Patents

Composiciones de carbamato fenilalquilo

Info

Publication number
CR10793A
CR10793A CR10793A CR10793A CR10793A CR 10793 A CR10793 A CR 10793A CR 10793 A CR10793 A CR 10793A CR 10793 A CR10793 A CR 10793A CR 10793 A CR10793 A CR 10793A
Authority
CR
Costa Rica
Prior art keywords
alkyl carbamate
phenyl alkyl
carbamate compositions
compositions
carbamate compound
Prior art date
Application number
CR10793A
Other languages
English (en)
Inventor
N Pandey Ramendra
Mascaro Tracey
Mccool James
Altan Stanley
M Railkar Aniruddha
Clark Hinton
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39111848&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CR10793(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of CR10793A publication Critical patent/CR10793A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A61P25/10—Antiepileptics; Anticonvulsants for petit-mal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A61P25/12—Antiepileptics; Anticonvulsants for grand-mal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Inorganic Chemistry (AREA)
  • Psychiatry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La presente invencion se relaciona con una composicion de un compuesto de carbamato fenilalquilo que resulta en estabilidad mejorada, en donde la composicion comprende un compuesto de carbamato fenilalquilo en una mezcla con una cantidad efectiva de uno o mas excipientes y, en donde por lo menos un excipiente es dihidrato de fosfato de calcio dibasico.
CR10793A 2006-10-13 2009-05-13 Composiciones de carbamato fenilalquilo CR10793A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US82935506P 2006-10-13 2006-10-13

Publications (1)

Publication Number Publication Date
CR10793A true CR10793A (es) 2009-09-29

Family

ID=39111848

Family Applications (1)

Application Number Title Priority Date Filing Date
CR10793A CR10793A (es) 2006-10-13 2009-05-13 Composiciones de carbamato fenilalquilo

Country Status (23)

Country Link
US (1) US20080090903A1 (es)
EP (1) EP2089002A1 (es)
JP (1) JP2010506846A (es)
KR (1) KR20090067210A (es)
CN (1) CN101663026A (es)
AR (1) AR063294A1 (es)
AU (1) AU2007313018A1 (es)
BR (1) BRPI0719236A2 (es)
CA (1) CA2673526A1 (es)
CL (1) CL2007002943A1 (es)
CO (1) CO6190539A2 (es)
CR (1) CR10793A (es)
EA (1) EA200970378A1 (es)
IL (1) IL198144A0 (es)
MX (1) MX2009003929A (es)
NI (1) NI200900055A (es)
NO (1) NO20091492L (es)
PE (1) PE20080887A1 (es)
SV (1) SV2009003222A (es)
TW (1) TW200831134A (es)
UY (1) UY30643A1 (es)
WO (1) WO2008048802A1 (es)
ZA (1) ZA200903284B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8263652B2 (en) 2007-10-31 2012-09-11 Sk Biopharmaceuticals Co., Ltd. Stabilized pediatric suspension of carisbamate
US9018253B2 (en) 2010-07-02 2015-04-28 Bio-Pharm Solutions Co., Ltd. Phenylcarbamate compound and muscle relaxant containing the same
CN104628603B (zh) * 2010-07-02 2017-08-15 比皮艾思药物研发有限公司 苯基氨基甲酸酯化合物及含有苯基氨基甲酸酯化合物的肌肉松弛剂
US8609849B1 (en) 2010-11-30 2013-12-17 Fox Chase Chemical Diversity Center, Inc. Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
WO2013100568A1 (en) 2011-12-27 2013-07-04 Bio-Pharm Solutions Co., Ltd. Phenyl carbamate compounds for use in preventing or treating stroke
WO2014097137A2 (en) * 2012-12-18 2014-06-26 Mahesh Kandula Compositions and methods for the treatment of seizures and neurologic diseases
EP2970111A4 (en) * 2013-03-12 2017-01-18 Bio-Pharm Solutions Co., Ltd. Phenyl carbamate compound and a composition for preventing or treating a nerve gas-induced disease comprising the same
WO2014142477A1 (en) 2013-03-12 2014-09-18 Bio-Pharm Solutions Co., Ltd. Phenyl carbamate compounds for use in preventing or treating pediatric epilesy and epilesy-related syndromes
JP6807941B2 (ja) * 2016-02-29 2021-01-06 バイオ−ファーム ソリューションズ カンパニー リミテッド スルファメート誘導体化合物、その製造方法および用途
BR112018067674B1 (pt) 2016-02-29 2023-01-10 Bio-Pharm Solutions Co., Ltd. Compostos derivados de carbamato, composição farmacêutica e seus usos para tratamento ou prevenção de distúrbios do snc e/ou dor

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3265728A (en) * 1962-07-18 1966-08-09 Armour Pharma Substituted phenethyl carbamates
US5698588A (en) * 1996-01-16 1997-12-16 Yukong Limited Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol
US20010034365A1 (en) * 1996-01-16 2001-10-25 Choi Yong Moon Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol
FR2758459B1 (fr) * 1997-01-17 1999-05-07 Pharma Pass Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation
US20020147229A1 (en) * 2000-08-17 2002-10-10 Allerton Charlotte Moira Norfor Pharmaceuticals
EP1450783A1 (en) * 2001-10-08 2004-09-01 Sun Pharmaceuticals Industries Ltd. New anti-asthmatic drug (asmakure) from indigenous herbs to cure the disease asthma

Also Published As

Publication number Publication date
CN101663026A (zh) 2010-03-03
WO2008048802A1 (en) 2008-04-24
US20080090903A1 (en) 2008-04-17
MX2009003929A (es) 2009-06-26
CO6190539A2 (es) 2010-08-19
CL2007002943A1 (es) 2008-04-18
ZA200903284B (en) 2010-07-28
BRPI0719236A2 (pt) 2014-07-08
CA2673526A1 (en) 2008-04-24
NO20091492L (no) 2009-07-09
EA200970378A1 (ru) 2009-10-30
NI200900055A (es) 2010-02-01
TW200831134A (en) 2008-08-01
KR20090067210A (ko) 2009-06-24
EP2089002A1 (en) 2009-08-19
UY30643A1 (es) 2008-05-02
IL198144A0 (en) 2009-12-24
JP2010506846A (ja) 2010-03-04
AU2007313018A1 (en) 2008-04-24
PE20080887A1 (es) 2008-06-28
AR063294A1 (es) 2009-01-21
SV2009003222A (es) 2009-10-15

Similar Documents

Publication Publication Date Title
CR10793A (es) Composiciones de carbamato fenilalquilo
NI200900053A (es) Composiciones de fenilalquilamino carbamato
UY30843A1 (es) Derivados de isoquinolona sustituidos con ciloalquilamina
CR10479A (es) Modulares bencimidazolicos de vr1
HN2011000699A (es) El compuesto (s)-1-({4-metil-5-[2-(2,2,2-trifluoro-1,1-dimetil-etil)-piridin-4-il]-tiazol-2-il}-amida) de 2-amida del acido pirrolidin-1,2-dicarboxilico en forma libre o de sal y composiciones y composicion farmaceutica que lo contiene.
BRPI0514766A (pt) composições farmacêuticas
CL2011001933A1 (es) Compuestos derivados de tetrahidropirano; y composicion pesticida que comprende a dichos compuestos.
CR9028A (es) Composiciones fungicidas sinergicas
UY29266A1 (es) Compuestos de piridazinona
GT200500102A (es) Compuestos de aril-o-heteroarilamida ortosustituidos
TR201906416T4 (tr) Hiv inhibitörü bileşiklerin fosfonat analogları.
UY30778A1 (es) Compuestos de 5,6-dihidro-1h-piridin-2-ona
EA200701306A1 (ru) Лиофилизация виросом
CL2008001693A1 (es) Compuestos derivados de piridil-pirimidinil-amino; composicion fungicida que comprende a dichos compuestos; y metodo para controlar los hongos fitopatogenos de los cultivos; y compuesto intermediario.
BRPI0712889A8 (pt) composto, processo para a preparação de um composto, composto intermediário, e, composição farmacêutica.
UY31925A (es) Isoquinolinas e isoquinolinonas sustituidas
PA8846901A1 (es) Inhibidores de cinasa akt y p70 s6.
BRPI0516602A (pt) composto, e, composição farmacêutica
HN2011000404A (es) Derivados de enfumafungina y composicion comprendiendo los mismos
BR112012024329A2 (pt) composição endoparasiticidas
CR10764A (es) Cristal novedoso de (s)-(+)-2-(2-clorofenil)-2-hidroxietil carbamato
BR112012025927A2 (pt) melhoras em ou relacionadas a compostos orgânicos
DK1531831T3 (da) Fosinoprilformulering
UY32360A (es) Compuestos de etanamina y métodos de utilización de los mismos 545
CL2008001351A1 (es) Compuestos insecticidas y/o acaricidas derivados de tiourea; uso de dichos compuestos; composicion que los contiene; procedimiento para controlar plagas; y procedimiento para la preparacion de dichos compuestos.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)